OpenURL Connection Search

Select item for more details and to access through your institution.

Preoperative determination of several serum tumor markers in patients with primary epithelial ovarian carcinoma.
Published in:
1999
By:
- Kudoh, Kazuya;
- Kikuchi, Yoshihiro;
- Kita, Tsunekazu;
- Tode, Takehiko;
- Takano, Masashi;
- Hirata, Junko;
- Mano, Yoshinori;
- Yamamoto, Kenji;
- Nagata, Ichiro;
- Kudoh, K;
- Kikuchi, Y;
- Kita, T;
- Tode, T;
- Takano, M;
- Hirata, J;
- Mano, Y;
- Yamamoto, K;
- Nagata, I
Publication type:
journal article
Effect of culture supernatants of endometriotic lesions, uterine endometrium and peritoneum from rats with experimental endometriosis on the natural killer activity of spleen cells.
Published in:
1996
By:
- Mizumoto, Yoshifumi;
- Hirata, Junko;
- Tokuoka, Susumu;
- Furuya, Kenichi;
- Kikuchi, Yoshihiro;
- Nagata, Ichiro;
- Mizumoto, Y;
- Hirata, J;
- Tokuoka, S;
- Furuya, K;
- Kikuchi, Y;
- Nagata, I
Publication type:
journal article
Endometriotic tissues produce immunosuppressive factors.
Published in:
1994
By:
- Hirata, Junko;
- Kikuchi, Yoshihiro;
- Imaizumi, Eije;
- Tode, Takehiko;
- Nagata, Ichiro;
- Hirata, J;
- Kikuchi, Y;
- Imaizumi, E;
- Tode, T;
- Nagata, I
Publication type:
journal article
UGT1A1 genotype-specific phase I and pharmacokinetic study for combination chemotherapy with irinotecan and cisplatin: a Saitama tumor board study.
Published in:
European Journal of Gynaecological Oncology, 2013, v. 34, n. 2, p. 120
By:
- Takano, M.;
- Goto, T.;
- Hirata, J.;
- Horie, K.;
- Takahashi, M.;
- Yokota, H.;
- Kino, N.;
- Kudoh, K.;
- Kikuchi, Y.
Publication type:
Article
Effect of Korean red ginseng on psychological functions in patients with severe climacteric syndromes.
Published in:
1999
By:
- Tode, T.;
- Kikuchi, Y.;
- Hirata, J.;
- Kita, T.;
- Nakata, H.;
- Nagata, I.
Publication type:
journal article
Total lactate dehydrogenase and its isozymes in serum from patients with primary carcinoma of the ovary.
Published in:
1991
By:
- Kikuchi, Yoshihiro;
- Hisano, Atsushi;
- Kuki, Eiichi;
- Hirata, Junko;
- Nagata, Ichiro;
- Kikuchi, Y;
- Hisano, A;
- Kuki, E;
- Hirata, J;
- Nagata, I
Publication type:
journal article
Polyneuropathy in acute megakaryoblastic leukemia.
Published in:
1991
By:
- Nishi, Yoshihiro;
- Yufu, Yuji;
- Shinomiya, Sachiko;
- Abe, Yasunobu;
- Takahira, Hiroyuki;
- Muta, Koichiro;
- Hirata, Jouji;
- Nishimura, Junji;
- Nawata, Hajime;
- Nishi, Y;
- Yufu, Y;
- Shinomiya, S;
- Abe, Y;
- Takahira, H;
- Muta, K;
- Hirata, J;
- Nishimura, J;
- Nawata, H
Publication type:
journal article
High-temperature-required protein A2 as a predictive marker for response to chemotherapy and prognosis in patients with high-grade serous ovarian cancers.
Published in:
British Journal of Cancer, 2015, v. 112, n. 4, p. 739, doi. 10.1038/bjc.2015.1
By:
- Miyamoto, M;
- Takano, M;
- Iwaya, K;
- Shinomiya, N;
- Goto, T;
- Kato, M;
- Suzuki, A;
- Aoyama, T;
- Hirata, J;
- Nagaoka, I;
- Tsuda, H;
- Furuya, K
Publication type:
Article
High algal production rates achieved in a shallow outdoor flume.
Published in:
Biotechnology & Bioengineering, 1986, v. 28, n. 2, p. 191, doi. 10.1002/bit.260280207
By:
- Laws, E. A.;
- Taguchi, S.;
- Hirata, J.;
- Pang, L.
Publication type:
Article
Time-to-Event Analysis of Polatuzumab Vedotin-Induced Peripheral Neuropathy to Assist in the Comparison of Clinical Dosing Regimens.
Published in:
CPT: Pharmacometrics & Systems Pharmacology, 2017, v. 6, n. 6, p. 401, doi. 10.1002/psp4.12192
By:
- Lu, D;
- Gillespie, WR;
- Girish, S;
- Agarwal, P;
- Li, C;
- Hirata, J;
- Chu, Y‐W;
- Kagedal, M;
- Leon, L;
- Maiya, V;
- Jin, JY
Publication type:
Article
Integrated Two-Analyte Population Pharmacokinetic Model for Antibody-Drug Conjugates in Patients: Implications for Reducing Pharmacokinetic Sampling.
Published in:
CPT: Pharmacometrics & Systems Pharmacology, 2016, v. 5, n. 12, p. 665, doi. 10.1002/psp4.12137
By:
- Lu, D;
- Gibiansky, L;
- Agarwal, P;
- Dere, RC;
- Li, C;
- Chu, Y‐W;
- Hirata, J;
- Joshi, A;
- Jin, JY;
- Girish, S
Publication type:
Article
Cause of death and prognosis of patients (pts) with primary refractory disease, and prognosis of pts reaching PFS24: Descriptive analysis of POLARIX.
Published in:
Hematological Oncology, 2023, v. 41, p. 432, doi. 10.1002/hon.3164_318
By:
- Herbaux, C.;
- Dietrich, S.;
- McMillan, A.;
- Thieblemont, C.;
- Gonzalez‐Barca, E.;
- Pinto, A.;
- Fogliatto, L.;
- Matasar, M.;
- Lee, C.;
- Hernandez, J.;
- Hirata, J.;
- Ho, R.;
- Launonen, A.;
- Boissard, F.
Publication type:
Article
Pola‐R‐CHP versus R‐CHOEP in young patients with high‐risk diffuse large B‐cell lymphoma.
Published in:
Hematological Oncology, 2023, v. 41, p. 420, doi. 10.1002/hon.3164_308
By:
- Lenz, G.;
- Tilly, H.;
- Ziepert, M.;
- Altmann, B.;
- Craine, V.;
- Yan, M.;
- Herbaux, C.;
- Frontzek, F.;
- Nickelsen, M.;
- Hirata, J.;
- Sahin, D.;
- Lee, C.;
- Morschhauser, F.;
- Schmitz, N.
Publication type:
Article
Subgroup analysis of elderly patients (pts) with diffuse large B‐cell lymphoma (DLBCL) in the Phase 3 POLARIX study.
Published in:
Hematological Oncology, 2023, v. 41, p. 416, doi. 10.1002/hon.3164_306
By:
- Hu, B.;
- Reagan, P. M.;
- Sehn, L. H.;
- Sharman, J.;
- Hertzberg, M.;
- Zhang, H.;
- Kim, A.;
- Herbaux, C.;
- Molina, L.;
- Maruyama, D.;
- Smolewski, P.;
- Stenner, F.;
- Craine, V.;
- Kothari, R.;
- Hirata, J.;
- Sahin, D.;
- Sugidono, M.;
- Lee, C.;
- Tilly, H.
Publication type:
Article
Patient‐ versus clinician‐reported symptoms in the POLARIX study.
Published in:
Hematological Oncology, 2023, v. 41, p. 414, doi. 10.1002/hon.3164_305
By:
- Thompson, C. A.;
- Mehta‐Shah, N.;
- Flowers, C.;
- Salles, G.;
- Tilly, H.;
- Chua, N.;
- Casasnovas, R.;
- Miall, F.;
- Kim, T. M.;
- Tsai, C.;
- Nasta, S.;
- Lee, S. T.;
- Craine, V.;
- Campinha‐Bacote, A.;
- Hirata, J.;
- Lee, C.;
- Sugidono, M.;
- Friedberg, J. W.
Publication type:
Article
IMMUNE CONTEXTURE ANALYSIS IN POLARIX SUGGESTS RESPONSE TO POLA‐R‐CHP TREATMENT REDUCES TUMOR MICROENVIRONMENT DEPENDENCY.
Published in:
Hematological Oncology, 2023, v. 41, p. 223, doi. 10.1002/hon.3163_146
By:
- Morschhauser, F.;
- Hatzi, K.;
- Lenz, G.;
- Herrera, A. F.;
- Flowers, C. R.;
- Trněný, M.;
- Burke, J. M.;
- Hou, J.;
- Staber, P. B.;
- Hawkes, E. A.;
- Izutsu, K.;
- Le Gouill, S.;
- Belada, D.;
- Tucci, A.;
- Yan, M.;
- Harris, W.;
- Hirata, J.;
- Lee, C.;
- Jiang, Y.;
- Jardin, F.
Publication type:
Article
CIRCULATING TUMOR DNA (CTDNA) STATUS AND CLINICAL OUTCOMES IN PATIENTS (PTS) WITH PREVIOUSLY UNTREATED DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) IN THE POLARIX STUDY.
Published in:
Hematological Oncology, 2023, v. 41, p. 175, doi. 10.1002/hon.3163_111
By:
- Herrera, A. F.;
- Tracy, S.;
- Sehn, L. H.;
- Jardin, F.;
- Lenz, G.;
- Trněný, M.;
- Salles, G.;
- Flowers, C. R.;
- Tilly, H.;
- Sharman, J. P.;
- Friedberg, J. W.;
- Balasubramanian, S.;
- Raghavan, V.;
- Hirata, J.;
- Lee, C.;
- Jiang, Y.;
- Morschhauser, F.
Publication type:
Article
POLATUZUMAB VEDOTIN + OBINUTUZUMAB + VENETOCLAX IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL): PRIMARY ANALYSIS OF A PHASE 1B/2 TRIAL.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.23_2880
By:
- Bannerji, R.;
- Yuen, S.;
- Phillips, T.;
- Arthur, C.;
- Isufi, I.;
- Marlton, P.;
- Seymour, J. F.;
- Corradini, P.;
- Molinari, A.;
- Gritti, G.;
- Emmons, R.;
- Hirata, J.;
- Musick, L.;
- Saha, S.;
- Croft, B.;
- Flowers, C.
Publication type:
Article
POLATUZUMAB VEDOTIN + RITUXIMAB + LENALIDOMIDE IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL): PRIMARY ANALYSIS OF A PHASE 1B/2 TRIAL.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.155_2880
By:
- Diefenbach, C;
- Abrisqueta, P;
- Gonzalez-Barca, E;
- Panizo, C;
- Arguinano Perez, J. Maria;
- Miall, F;
- Bastos-Oreiro, M;
- Lopez-Guillermo, A;
- Banerjee, L;
- McMillan, A;
- Hirata, J;
- Musick, L;
- Saha, S;
- Croft, B;
- Seymour, E
Publication type:
Article
POLATUZUMAB VEDOTIN (POLA) + OBINUTUZUMAB (G) + LENALIDOMIDE (LEN) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL): PHASE IB/II INTERIM ANALYSIS.
Published in:
Hematological Oncology, 2019, v. 37, p. 175, doi. 10.1002/hon.132_2629
By:
- Diefenbach, C.;
- Kahl, B.;
- Banerjee, L.;
- McMillan, A.;
- Ramchandren, R.;
- Miall, F.;
- Briones, J.;
- Cordoba, R.;
- Gonzalez‐Barca, E.;
- Panizo, C.;
- Hirata, J.;
- Chang, N.;
- Musick, L.;
- Abrisqueta, P.
Publication type:
Article
POLATUZUMAB VEDOTIN (POLA) + OBINUTUZUMAB (G) + LENALIDOMIDE (LEN) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL): PHASE IB/II INTERIM ANALYSIS.
Published in:
Hematological Oncology, 2019, v. 37, p. 175, doi. 10.1002/hon.132_2629
By:
- Diefenbach, C.;
- Kahl, B.;
- Banerjee, L.;
- McMillan, A.;
- Ramchandren, R.;
- Miall, F.;
- Briones, J.;
- Cordoba, R.;
- Gonzalez‐Barca, E.;
- Panizo, C.;
- Hirata, J.;
- Chang, N.;
- Musick, L.;
- Abrisqueta, P.
Publication type:
Article
POLA-R-CHP: POLATUZUMAB VEDOTIN COMBINED WITH RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, PREDNISONE FOR PATIENTS WITH PREVIOUSLY UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA.
Published in:
Hematological Oncology, 2017, v. 35, p. 90, doi. 10.1002/hon.2437_79
By:
- Tilly, H.;
- Sharman, J.;
- Bartlett, N.;
- Morschhauser, F.;
- Haioun, C.;
- Munoz, J.;
- Chen, A.;
- Lamy, T.;
- Wang, L.;
- Penuel, E.;
- Hirata, J.;
- Lee, C.;
- Salles, G.
Publication type:
Article
Racial differences in presentation and management of follicular non-Hodgkin lymphoma in the United States: Report from the National LymphoCare Study.
Published in:
2012
By:
- Nabhan C;
- Byrtek M;
- Taylor MD;
- Friedberg JW;
- Cerhan JR;
- Hainsworth JD;
- Miller TP;
- Hirata J;
- Link BK;
- Flowers CR
Publication type:
Journal Article
The involvement of FOXO1 in cytotoxic stress and drug-resistance induced by paclitaxel in ovarian cancers.
Published in:
2008
By:
- Goto, T.;
- Takano, M.;
- Hirata, J.;
- Tsuda, H.
Publication type:
journal article

Found: 24